Hematology/Oncology

Top Story

Liver cancer recurrence rates similar regardless of DAA experience

January 21, 2019
In the Journals Plus

Changes in cancer trial designs after enrollment initiation are common, often unreported

January 21, 2019
Changes in the design of cancer drug trials after patient enrollment began appeared common and were left frequently unreported, according to a research letter published…

Addition of ibrutinib to chemotherapy does not extend PFS in metastatic pancreatic cancer

January 21, 2019
A randomized phase 3 trial designed to assess the addition of ibrutinib to chemotherapy for patients with metastatic pancreatic cancer failed to meet its primary…
In the Journals Plus

Nivolumab response rates low among some patients with diffuse large B-cell lymphoma

January 21, 2019
Nivolumab monotherapy appeared associated with low overall response rates among patients with diffuse large B cell lymphoma who failed or were ineligible for
In the Journals Plus

Younger cancer survivors particularly vulnerable to financial hardship

January 21, 2019
Cancer survivors carry greater financial burdens related to medical bills and debt payments than individuals who never had cancer, according to an analysis of data from…
More Headlines »
CME CNE CPE

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immune checkpoint inhibitors into treatment algorithms for the management of advanced genitourinary…
More »
Video
Meeting News

VIDEO: Physician leadership development ‘now more than ever’ imperative

August 17, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next